Novo Holdings
Family officeCopenhagen · Pre-Seed–Late Stage · 25 people tracked
Investment thesis
Novo Holdings invests in life science companies and sustainable solutions that address healthcare and planetary health challenges. The firm operates with a long-term return perspective and focuses on generating attractive returns while promoting groundbreaking solutions in healthcare and bio-sustainability.
Source: firm website, verified Jul 21, 2026.
Team · 25 people
from the firm's website
What they invest in
from 10 of 14 portfolio companiesAI & Machine Learning ×4Biotech ×4Digital Health ×3Healthtech ×3Climate Tech ×2Data & Infrastructure ×2AgTech ×1Circular Economy ×1
HQs:United States×6
Investments · 14 tracked
founders shown can be your intro pathAmass provides an AI-powered scientific intelligence platform that indexes over 500 million documents including research papers, patents, clinical trials, regulatory filings, and drug data. It serves life science companies, research institutions, and investment teams by delivering cited, evidence-grounded answers across scientific workflows.
AI & Machine LearningBiotechData & Infrastructure
LanzaTech converts carbon-rich gases from industrial sources like steel mills and landfills into fuels and chemicals using synthetic biology. The company serves heavy industries seeking to reduce emissions and create value from waste streams.
Circular EconomyCleantechClimate Tech<UNKNOWN>, US
Dr. Jennifer Holmgren(CEO)Jennifer Holmgren(CEO)
Verana Health aggregates de-identified clinical data from a network of over 20,000 physicians in ophthalmology, urology, and neurology to power real-world evidence, clinical trial enablement, and quality reporting for pharmaceutical companies and healthcare providers using AI and machine learning.
AI & Machine LearningData & InfrastructureDigital HealthHealthtech
Sujay Jadhav(Chief Executive Officer)
Callio Therapeutics develops next-generation dual-payload antibody-drug conjugates (ADCs) with differentiated payload and linker technologies for targeted cancer treatment. The company's lead program is a dual-payload HER2-targeted ADC designed to deliver drug combinations to tumor cells.
BiotechMedical DevicesSeattle, US
Zachary Hornby(Chief Executive Officer)Piers Ingram(President, Co-Founder)Jerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)
Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches. It connects members with bilingual physicians, hospitals, and acupuncturists to deliver personalized care aligned with each community's cultural traditions and values.
HealthtechInsurTechSouthern California, US
ZELP develops technology to measure and reduce methane emissions from the livestock industry. The company serves farmers, producers, and governments seeking sustainable solutions that maintain farm profitability while addressing climate and food security challenges.
AgTechClimate TechImpact & Social GoodIoT
Francisco(Co-Founder, CEO)Patricio(Co-Founder, Chairman of the Board)
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)Marie De Vulder(Chief Legal Officer Co-founder)Guy Peeters(Chief Financial Officer Co-founder)John-Paul Gallivan(Head of Development Co-founder)
Genome Medical provides telehealth-enabled genetic services, including counseling, testing, and clinical trial access, primarily for individuals with rare conditions. The company partners with hospitals, health systems, and life sciences organizations to expand access to expert genetic guidance.
Digital HealthHealthtech
Portfolio company that completed successful Nasdaq IPO
Received strategic growth investment from Novo Holdings
Kebotix uses artificial intelligence, machine learning, and laboratory automation to discover and develop new materials and molecules. The company serves product manufacturers and industries seeking high-performance, environmentally friendly materials.
AI & Machine LearningDeep TechNew Materials
Portfolio company acquired by Lilly
Portfolio company acquired by Novartis
Reunion develops serotonergic psychedelic therapies for mental health conditions, targeting postpartum depression, adjustment disorder, and generalized anxiety disorder. The company is advancing luvesilocin, a clinical-stage drug candidate and patented prodrug designed to provide fast-acting antidepressive effects.
BiotechDigital HealthMental Health
Sahil V. Kirpekar(President and CEO)
Board seats · per SEC filings · 3
what is this? ⓘ$125M raise · filed Apr 2022 · via Anders Bendsen Spohr
$65M raise · filed Feb 2022 · via Anders Bendsen Spohr
$119.1M raise · filed Aug 2021 · via Anders Bendsen Spohr
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Novo Holdings invest at?
- Novo Holdings invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Novo Holdings focus on?
- Novo Holdings focuses on Biotech, Cleantech, Climate Tech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Novo Holdings located?
- Novo Holdings is headquartered in Copenhagen, DK.
Images
Similar investors
B Capital is a venture capital firm managing $12+ billion in assets under management with 200+ early to late-stage portfolio companies across 9 global locations. The firm operates dedicated stage-based funds supporting entrepreneurs throughout the company-building lifecycle.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Octopus Ventures is a pan-European early-stage venture capital firm that invests from pre-seed through Series A and beyond, with pre-seed investments typically at £100k and later-stage investments starting at £1 million.